With regard to the different models of payment, absolutely, but this is something that should be studied. I would suggest that our current payment model is not ideal and we need to look at how to improve upon the payment model.
From the point of view of the education around medication, and specifically certain restricted substances, I think that has been addressed within our medical schools. I think what needs to happen is that, again, this is the importance of the ongoing education of physicians. As everything changes so quickly in medicine, there needs to be ongoing, continuing professional development of physicians who are in practice. Certainly, one of the very helpful tools that have been developed in this area was actually developed with the support of FMRAC.
I don't know if Fleur-Ange wants to speak to that.